Abstract: A self-clamping structure for solving a short-circuit resistance problem of amorphous alloy transformers comprises an A-phase coil, a B-phase coil and a C-phase coil which are horizontally arranged, the A-phase coil being in close contact with the B-phase coil, and the B-phase coil being in close contact with the C-phase coil. By using a solidified low-voltage coil as a fastening splint and binding with a high-strength binding strap, the low-voltage coils of the A-phase and the B-phase clamp and fix a weak portion between the A and B phases; and the low-voltage coil of the B-phase and the C-phase clamp and fix a weak portion between the B and C phases. Outer sides of the A- and C-phase coils are each provided with a high-strength insulation splint, so that the splint and the low-voltage coil of corresponding phase constitute the splint pair to clamp and fix the corresponding weak portion.

Abstract: An encoding method includes obtaining an image frame to be encoded. The image frame includes one or more image blocks. The method further includes determining one or more complexities of the one or more image blocks. Each of the one or more complexities corresponds to one of the one or more image blocks. The method also includes encoding the one or more image blocks based on the one or more complexities.

Abstract: Encoding apparatuses are provided. The encoding apparatus includes: a first buffer configured to buffer a quantized coefficient of an image block that is input by a quantization circuit; an information generation circuit configured to detect the quantized coefficient of the image block sequentially to obtain run-length encoding information; a second buffer configured to buffer the run-length encoding information generated by the information generation circuit; and a processing circuit configured to: when the second buffer stores run-length encoding information, read the run-length encoding information from the second buffer, read the quantized coefficient corresponding to the run-length encoding information from the first buffer, and output the run-length encoding information and the corresponding quantized coefficient to an entropy encoding circuit.

Abstract: A computer-implemented method for controlling bit rate includes determining a difference between a cumulative number of bits used to encode one or more slices of a frame up to and including a first slice encoded using a first coding parameter and a maximum number of bits allowed to encode the one or more slices of the frame, updating a coding parameter threshold based at least in part on a counter that indicates a number of times when one or more coding parameters used to encode the one or more slices reach or exceed the coding parameter threshold, and determining a second coding parameter used to encode a second slice of the frame based at least in part on the difference and the updated coding parameter threshold.

Abstract: A network computer system that determines metrics related to effort and cost on the part of deliverers who deliverer items for delivery orders. The network computer system can implement operations to facilitate or mitigate features that cause deliverers to expend effort or cost when completing delivery tasks.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: A method for video decoding includes obtaining a bit stream for a sequence of image frames, each of which is partitioned into a plurality of sections according to a partition scheme, obtaining an indicator indicating that decoding prediction dependency for a particular section of each image frame in the sequence of image frames is constrained within said particular section, performing decoding prediction for said particular section of a first image frame in the sequence of image frames based on said particular section of a second image frame in the sequence of image frames, and decoding said particular section of the first image frame based on the decoding prediction.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: A data rate control method includes determining an adjustment value of a first encoding parameter for encoding a first strip based on a quota of the first strip included in a frame that has not been encoded and based on a quota of at least one already encoded strip included in the frame. At least one of the quota of the first strip and the quota of the at least one already encoded strip relates to a number of shares of bits used for encoding a strip. The data rate control method also includes determining the first encoding parameter based on the adjustment value.

Abstract: A method for video decoding includes obtaining a mapping that corresponds a set of image regions in a first decoded image frame to at least a portion of a curved view, determining a padding scheme for the first decoded image frame based on the mapping, and constructing an extended image for the first decoded image frame according to the padding scheme. The extended image comprises one or more padding pixels. The method further includes using the extended image as a reference frame to obtain a second decoded image frame.

Abstract: A computer-implemented method for controlling bit rate includes determining a difference between a cumulative number of bits used to encode one or more slices of a frame up to and including a first slice encoded using a first coding parameter and a maximum number of bits allowed to encode the one or more slices of the frame, updating a coding parameter threshold based at least in part on a counter that indicates a number of times when one or more coding parameters used to encode the one or more slices reach or exceed the coding parameter threshold, and determining a second coding parameter used to encode a second slice of the frame based at least in part on the difference and the updated coding parameter threshold.

Abstract: An electronic device includes a slice splitter and a slice encoder. The slide splitter is configured to split video data into a plurality of slices. Each slice contains a plurality of data blocks and each data block contains a plurality of data points. The slice encoder includes one or more video encoding circuits and is configured to encode the data blocks in a plurality of data streams concurrently to obtain encoded data streams and combine the encoded data streams into a combined data stream.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: A self-clamping structure for solving a short-circuit resistance problem of amorphous alloy transformers comprises an A-phase coil, a B-phase coil and a C-phase coil which are horizontally arranged, the A-phase coil being in close contact with the B-phase coil, and the B-phase coil being in close contact with the C-phase coil. By using a solidified low-voltage coil as a fastening splint and binding with a high-strength binding strap, the low-voltage coils of the A-phase and the B-phase clamp and fix a weak portion between the A and B phases; and the low-voltage coil of the B-phase and the C-phase clamp and fix a weak portion between the B and C phases. Outer sides of the A- and C-phase coils are each provided with a high-strength insulation splint, so that the splint and the low-voltage coil of corresponding phase constitute the splint pair to clamp and fix the corresponding weak portion.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.

Abstract: The present invention relates to fibronectin-based scaffold domain proteins that bind to myostatin. The invention also relates to the use of these proteins in therapeutic applications to treat muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. The invention further relates to cells comprising such proteins, polynucleotides encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the proteins.